Elevated NKCC1 expression and decreased KCC2 expression were observed in glioma tumors excised from individuals with medically intractable epilepsy112, 113; this finding was further validated by in vitro experiments conducted by Conti et al.114. The gene discussed is SLC12A5; the disease is central nervous system cancer.